Family Medicine · Raymore, MO
NPI
1235131574
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
402 W Pine St, Ste K
Raymore, MO, 64083
Phone (816) 322-0701
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
938 services
Medicare patients, 2024
276
Average age 66
Drug cost, 2024
$3.4M
31,912 prescriptions
Company payments, 2025
$11K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christine L Moore was code 99213 (office e&m - established), 686 times for 236 patients. In total Christine L Moore billed 938 services in 13 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 686 | 236 | $45.62 | $31K |
| 99214 Office E&M - Established | Office | 113 | 87 | $72.35 | $8,176 |
| 99211 Office E&M - Established | Office | 60 | 40 | $10.21 | $612 |
| 81003 Clinical Chemistry | Office | 21 | 17 | $2.20 | $46.2 |
| 99204 Office E&M - New | Office | 21 | 21 | $96.11 | $2,018 |
| 99212 Office E&M - Established | Office | 16 | 15 | $29.64 | $474 |
By year: 2022 $54K for 1,201 services; 2023 $53K for 1,086 services; 2024 $45K for 938 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 21 | 17 | $2.20 | $46.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Christine L Moore prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,333 prescriptions and refills. In total Christine L Moore wrote 31,912 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,333 | 1,333 | 149 | $45K |
| Levothyroxine Sodium Generic | 1,155 | 2,316 | 224 | $9,622 |
| Atorvastatin Calcium Generic | 1,014 | 2,096 | 217 | $7,578 |
| Gabapentin Generic | 986 | 1,320 | 152 | $18K |
| Pantoprazole Sodium Generic | 698 | 1,322 | 149 | $6,669 |
| Tizanidine Hcl Generic | 673 | 925 | 114 | $9,277 |
| Alprazolam Generic | 656 | 742 | 95 | $4,380 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 651 | 785 | 139 | $19K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 548 | 548 | 59 | $19K |
| Omeprazole Generic | 529 | 1,054 | 113 | $8,612 |
| Amlodipine Besylate Generic | 483 | 949 | 103 | $2,198 |
| Lisinopril Generic | 454 | 853 | 91 | $2,332 |
| Meloxicam Generic | 423 | 655 | 87 | $1,266 |
| Losartan Potassium Generic | 417 | 966 | 99 | $3,131 |
| Duloxetine Hcl Generic | 398 | 636 | 70 | $7,595 |
Brand drugs: 4,579 claims; generic drugs: 27,108 claims; opioid claims: 2,958.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christine L Moore $11K ($11K in general payments such as food, travel and fees) from 29 companies. The largest payer was Abbvie Inc. with $4,171.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $4,171 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 16 | $4,142 |
| Amgen Inc. AMGN | 17 | $378 |
| Pfizer Inc. PFE | 20 | $314 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 10 | $207 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $176 |
| Lilly USA, LLC LLY | 8 | $135 |
| Axsome Therapeutics, Inc. AXSM | 6 | $129 |
| Medtronic, Inc. MDT | 1 | $108 |
| Lundbeck LLC | 5 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.